A Study In Adults With Moderate To Severe Dermatomyositis

NCT03181893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatomyositis

Interventions

DRUG: PF-06823859 low
DRUG: Placebo Arm
DRUG: PF-06823859 high

Sponsor

Pfizer